Huge dose of measles vaccine treats woman's blood cancer in trial

05/14/2014 | Star Tribune (Minneapolis-St. Paul, Minn.)

Mayo Clinic researchers have tested a new approach to treating blood cancer by administering single massive doses of the measles vaccine to two patients, one of whom achieved remission in the proof-of-concept study. Multiple myeloma tumors are vulnerable to the measles virus, and the trial showed that the viral components of the vaccine were effective against cancer cells. In the study, the patients received enough vaccine for 10 million inoculations.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC